The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study
Abstract
Background and Purpose— Although the relation between serum LDL cholesterol level and coronary heart disease (CHD) is well established, its relation with stroke subtypes is less clear. Methods— A total of 2351 inhabitants age ≥40 years in a Japanese community were followed up for 19 years. Results— During follow-up, 271 subjects developed stroke and 144 developed CHD. Whereas the age- and sex-adjusted incidences of CHD significantly increased with increasing LDL cholesterol levels ( P for trend <0.001), the associations between LDL cholesterol level and the incidences of ischemic or hemorrhagic stroke were not significant. The age- and sex-adjusted incidences of atherothrombotic infarctions (ATIs) and lacunar infarctions (LIs) significantly increased with increasing LDL cholesterol level ( P for trend=0.03 for ATIs and=0.02 for LIs), but no such association was observed for cardioembolic infarction. After multivariate adjustment, the positive associations of LDL cholesterol level with the risks of ATI and CHD remained significant ( P for trend=0.02 for ATIs and=0.03 for CHD), whereas the association with LIs was not significant. The risk of ATI significantly increased in the fourth quartile of LDL cholesterol compared with the first quartile (multivariate-adjusted hazard ratio=2.84; 95% CI, 1.17 to 6.93). The multivariate-adjusted risks for developing nonembolic infarction (ATIs and LIs) and CHD were significantly elevated in the groups with elevated LDL cholesterol values with and without the metabolic syndrome. Conclusions— Our findings suggest that an elevated LDL cholesterol level is a significant risk factor for developing ATI as well as CHD, and these associations are independent of the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the increase in hazard ratio for the CAD incidence and mortality following an elevation in LDL-C has been validated in cohort studies involving the Japanese36–40).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“An elevated LDL-C level also increased the risk for cerebral thrombosis (except lacunar infarction) among the subtypes of ischemic stroke36).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“among stroke cases, the percentage of atherothrombotic cerebrovascular disease in which LDL-C was a risk factor is approximately 20%36)”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“LDL-C is also a risk factor for atherothrombotic cerebral infarction36), and the effectiveness of statins to decrease the incidence of atherothrombotic cerebral infarction was confirmed in a Japanese population by the J-STARS study619).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“The results of the Hisayama study, which investigated cerebral infarction risk by type, demonstrated that the LDL-C level is a risk factor for atherothrombotic cerebral infarction.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“However, the results of epidemiological studies conducted in Japan have indicated that there is no significant relationship between the serum cholesterol levels (TC, LDL-C, and non-HDL-C) and the incidence rate of noncardiogenic cerebral infarction36, 38, 40, 57, 64, 78, 337).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“However, the LDL-C level is not related to the incidence of other types of cerebral infarction36).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,350
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Incidence of and risk factors for atrial fibrillation in older adults
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2455 · Cited by 1,462
Cited by
Sorted by citations
Items 201–235 of 235
Recurrent events and secondary prevention after acute cerebrovascular disease
Irewall, A.-L. (2017) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Current epidemiology of ischemic stroke in Japan
Kuroda, J. (2017) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.28.278
OBSOLETE: Lipids and Cardiovascular Diseases: Epidemiologic Perspectives
Okamura, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99596-5
Comprehensive risk assessment for the prevention of atherosclerotic diseases
Okamura, T. (2018) · Journal of the Japanese Coronary Association · doi:10.7793/jcoron.24.002
General view and medical therapy for polyvascular disease
Fukamachi, D. (2018) · Journal of the Japanese Coronary Association · doi:10.7793/jcoron.24.020
Stroke in the Elderly Population
Kamouchi, M. (2018) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-13-1762-0_9
Saha, B. B., Thu, K., & Wijayanta, A. T. (2018) · Evergreen · doi:10.5109/1957499
Öztürk, B., & Ünsal, M. A. (2019) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.588068
Prevention of Stroke by Lowering Blood Cholesterol Concentrations
Paciaroni, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316286234.017
A cohort study I was aiming for
Kiyohara, Y. (2020) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.31.624
Self-citationRuixiao, H., Peipei, L., Yajing, W., & Wu, J. (2019) · Research Square · doi:10.21203/rs.2.294/v1
Bando, H., Taneda, S., & Manda, N. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.266
(2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283433a91
TANAKA, R. (2009) · Juntendō Igaku/Juntendo igaku · doi:10.14789/pjmj.55.416
10. Overcoming Stroke from the Aspects of Internal Medicine
Terayama, Y. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.1881
Lipids and Cardiovascular Diseases: Epidemiologic Perspectives
Okamura, T., Sugiyama, D., Hirata, T., Kuwabara, K., & Hirata, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99596-6
2) Epidemiologic Insights of Cerebrovascular Event in Japan
Iso, H. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.1851
Lotfizadeh, M., Khaledifar, A., Heidari, F., & Khdemi, A. (2022) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2022.23
Prediction of Outcome of Newly Onset Cerebrovascular Stroke in HCV Infected Patients
Gadallah, A.-N. A.-A., Elbasuony, H. A. A., Mousa, W. A., Lashin, M. E., Al-Abyad, M. A., & Mohamed, A. A. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2622
Impact of Guideline Update on Lipid Management in Subacute Ischemic Stroke Patients
Ogawa, Y., & Sakoh, M. (2023) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.54.6_215
I. Revision of JAS Guidelines for Prevention of Atherosclerotic Cradiovascular Diseases in 2022
Okamura, T. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.157
VII. Lipid Management for Secondary Stroke Prevention
Kitagawa, K. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.202
Statin Therapy in Ischemic Stroke Patients with Atrial Fibrillation: Efficacy and Safety OutcomesPreprint
RAF and RAF NOAC-Investigators, Marvardi, M., Ferrante, M. N. V., Paciaroni, M., Abdul‐Rahim, A. H., Tsivgoulis, G. K., Seiffge, D. J., Engelter, S. T., Lyrer, P. A., Polymeris, A. A., et al. (2024) · medRxiv · doi:10.1101/2024.04.19.24306111
Choi, S. E., Bucci, T., Huang, J., Yiu, K., Tsang, C. T., Lau, K. K., Hill, A. M., Irving, G. J., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2024) · medRxiv · doi:10.1101/2024.05.21.24307724
Hattori, Y., Noda, K., Hori, M., Nakaoku, Y., Ogata, S., Murata, H., Nishimura, K., Nagai, A., Yamaguchi, S., Harada‐Shiba, M., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5345177
Furukawa, A., Tada, H., Sakata, K., Usui, S., & Takamura, M. (2026) · Internal Medicine · doi:10.2169/internalmedicine.6925-25
Cerebrovascular integrity maintenance and inflammation in atherosclerosis animal models
Cataldo, V. D. (2016) · theses.fr (ABES) · doi:10.70675/7b5a6c4bz3377z40fezbf48z5da7afd1a502
Lipids and Cardiovascular Diseases: Epidemiologic Perspectives
Nguyen, X.-M. T., Wilson, P. W. F., Okamura, T., Sugiyama, D., Hirata, T., Kuwabara, K., & Hirata, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00066-2
Low-density lipoprotein cholesterol and risk of cardiovascular disease in a working population
Hu, H., Nakagawa, T., Honda, T., Yamamoto, S., Kochi, T., Ogasawara, T., Gommori, N., Yamamoto, M., Miyamoto, T., Okazaki, H., et al. (2026) · Journal of Epidemiology · doi:10.2188/jea.je20260221
Kitsunai, H., Kito, K., Omori, K., Cho, K. Y., Nakamura, A., Takeuchi, J., NAGAI, S., Sakuma, I., & Nomoto, H. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70456
Huang, L., Huang, Z., Fandi, M., Xu, X., Zhang, Y., Ma, X., Geng, T., Hu, C., Li, S., Cao, G., et al. (2026) · Open Research (University of Surrey) · doi:10.1002/viw2.70205
Screening Local Residents for Postprandial Hyperglycemia in Community Pharmacies
Tokumo, K., Okada, M., Okamoto, S., Yamada, M., Kamishikiryo, J., Tsuchiya, D., Kojima, E., 横田, い., & Sugihara, N. (2026) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.52.735
Surendran, V., Nair, P., & Sreedharan, S. E. (2026) · Journal of Stroke Medicine · doi:10.1177/25166085261492813
Secondary prevention of stroke following Transient Ischaemic Attack : a mixed methods study
Lager, K. E. (2013) · Leicester Research Archive (University of Leicester)
Metadata
- Authors
- Imamura, T., Doi, Y., Arima, H., Yonemoto, K., Hata, J., Kubo, M., Tanizaki, Y., Ibayashi, S., Iida, M., & Kiyohara, Y.
- Affiliations
- Kyushu University (JP)
- Venue
- Stroke
- Published
- 2009-02
- Volume
- 40
- Issue
- 2
- Pages
- 382-388
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2053503164
- Cited by
- 235
- References
- 37
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 13 · 2023: 16 · 2022: 14 · 2021: 9 · 2020: 16 · 2019: 22 · 2018: 20 · 2017: 10 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 18 · 2012: 9
- FWCI
- 13.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Funders
- H2020 European Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- LDL cholesterol, stroke subtypes, coronary artery disease, atherothrombotic infarction, lacunar infarction, cardioembolic stroke, metabolic syndrome, stroke risk factors, Japanese population
- MeSH terms
- Age Factors, Aged, Analysis of Variance, Cardiovascular Diseases, Coronary Disease, Female, Follow-Up Studies, Health Surveys, Humans, Japan, Cholesterol, LDL, Male, Middle Aged, Myocardial Infarction, Terminology as Topic, Prospective Studies, Risk Factors, Sex Factors, Cohort Studies, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
